KR102597689B1 - Vaccine management system that prevents vaccination incident due to misvaccination and misregistration of vaccines, and method of providing vaccination service performed in the vaccine management system - Google Patents

Abstract

A vaccine management system and method for providing vaccination services are disclosed to prevent vaccination accidents due to incorrect vaccination and misregistration of vaccines. The disclosed vaccine management system includes an on-site code recognition device that recognizes the subject identification code of a person to be vaccinated and the vaccine identification code for vaccination printed on a syringe or vial, and the subject identification code and the vaccination transmitted from the on-site code recognition device. It includes an on-site terminal that displays on the screen check information that must be confirmed for vaccination of the vaccination target based on the vaccine identification code. At this time, the screen of the field terminal has a first display area displaying the identification information of the vaccination subject corresponding to the subject identification code among the check information and the vaccination corresponding to the vaccination vaccine identification code among the check information. and a second display area that displays user information.

Description

Vaccine management system that prevents vaccination incident due to misvaccination and misregistration of vaccines, and method of providing vaccination services performed in the vaccine management system vaccination service performed in the vaccine management system}

Embodiments of the present invention relate to a vaccine management system that prevents vaccination accidents due to incorrect vaccination and misregistration of vaccines, and a method of providing vaccination services performed in the vaccine management system.

Vaccines activate the human body's immune system by injecting artificially inactivated or attenuated pathogens into the human body before infection by the pathogen, thereby preventing or minimizing damage caused by the pathogen even if the human body is infected with the pathogen. It is used.

In general, vaccination services are provided in such a way that vaccines produced by manufacturers are received and registered at medical institutions, and medical staff administer the registered vaccines to vaccine recipients who visit the medical institutions.

In these vaccination services, vaccination accidents such as incorrect vaccination and misregistration may occur. Misvaccination is a vaccination accident in which a vaccine recipient is vaccinated with a different vaccine than the vaccine intended for vaccination, and misregistration is when the drug name, lot number, expiration date, etc. of the vaccine are incorrectly registered during the vaccine registration process, or when the vaccine recipient is incorrectly registered. This is a vaccination accident where vaccine A is administered but is incorrectly registered as vaccine B.

Therefore, technology is required to prevent vaccination accidents such as incorrect vaccination and misregistration in the process of providing vaccination services.

Korean Patent Publication No. 10-2022-0164948 (December 14, 2022) Korean Patent Publication No. 10-2022-0137223 (October 12, 2022) Korean Patent Publication No. 10-2022-0117406 (August 24, 2022)

The purpose of the present invention is to provide a vaccine management system that prevents vaccination accidents due to incorrect vaccination and misregistration of vaccines, and a method of providing vaccination services performed in the vaccine management system.

In addition, the object of the present invention is a vaccine management system that prevents misvaccination and misregistration accidents by confirming to vaccine recipients and medical staff whether the registered vaccine and the vaccine to be administered match before the vaccine is administered, and the vaccine It provides a method of providing vaccination services performed in a management system.

The objects of the present invention are not limited to the objects mentioned above, and other objects and advantages of the present invention that are not mentioned can be understood by the following description and will be more clearly understood by the examples of the present invention. Additionally, it will be readily apparent that the objects and advantages of the present invention can be realized by the means and combinations thereof indicated in the claims.

The vaccine management system according to an embodiment of the present invention includes an on-site code recognition device that recognizes the subject identification code of the person receiving the vaccine and the vaccine identification code for vaccination printed on the syringe or vial, and the on-site code recognition device transmitted from the on-site code recognition device. It includes an on-site terminal that displays on the screen check information that must be confirmed for vaccination of the vaccination subject based on the subject identification code and the vaccination vaccine identification code. At this time, the screen of the field terminal has a first display area displaying the identification information of the vaccination subject corresponding to the subject identification code among the check information and the vaccination corresponding to the vaccination vaccine identification code among the check information. and a second display area that displays user information.

In addition, a method of providing a vaccination service according to an embodiment of the present invention is a method of providing a vaccination service performed in a vaccine management system including an on-site code recognition device and an on-site terminal connected to communication, wherein the on-site code recognition device includes, Recognizing the subject identification code of the person to be vaccinated and the vaccine identification code for vaccination printed on the syringe or vial and transmitting it to the field terminal, wherein the field terminal is based on the subject identification code and the vaccine identification code for vaccination It includes the step of displaying check information that must be confirmed for vaccination of the vaccination target on the screen of the field terminal. At this time, the screen of the field terminal has a first display area displaying the identification information of the vaccination subject corresponding to the subject identification code among the check information and the vaccination corresponding to the vaccination vaccine identification code among the check information. and a second display area that displays user information.

According to the present invention, vaccination accidents due to incorrect vaccination and misregistration of vaccines can be prevented.

In addition, according to the present invention, before the vaccine is administered, vaccination accidents due to incorrect vaccination and misregistration can be prevented by confirming with the vaccine recipient and medical staff whether the registered vaccine matches the vaccine to be administered.

In addition, the effects of the present invention are not limited to the effects described above, and should be understood to include all effects that can be inferred from the configuration of the invention described in the detailed description or claims of the present invention.

Figure 1 is a diagram showing the schematic configuration of a vaccine management system according to an embodiment of the present invention.
Figure 2 is a diagram showing an example of a subject identification code and an inoculation vaccine identification code used in an embodiment of the present invention.
Figure 3 is a diagram showing an example of a vaccine identification code for wearing in an embodiment of the present invention.
Figure 5 is a flowchart of a method for providing vaccination services according to an embodiment of the present invention.
Figures 7 to 10 and Figure 12 are diagrams showing screens displayed on the display unit of a field terminal according to an embodiment of the present invention.
Figure 11 is a diagram for explaining the concept of follow-up management of a vaccinated person displayed on a user terminal according to an embodiment of the present invention.

Since the present invention can make various changes and have various embodiments, specific embodiments will be illustrated in the drawings and described in detail. However, this is not intended to limit the present invention to specific embodiments, and should be understood to include all changes, equivalents, and substitutes included in the spirit and technical scope of the present invention. While describing each drawing, similar reference numerals are used for similar components.

Terms such as “first”, “second”, etc. may be used to describe various components, but the components should not be limited by the terms. The above terms are used only for the purpose of distinguishing one component from another. The term “and/or” includes any of a plurality of related stated items or a combination of a plurality of related stated items.

The terms used herein are only used to describe specific embodiments and are not intended to limit the invention. Singular expressions include plural expressions unless the context clearly dictates otherwise. In this application, terms such as “comprise” or “have” are intended to designate the presence of features, numbers, steps, operations, components, parts, or combinations thereof described in the specification, but are not intended to indicate the presence of one or more other features. It should be understood that this does not exclude in advance the possibility of the existence or addition of elements, numbers, steps, operations, components, parts, or combinations thereof.

Unless otherwise defined, all terms used herein, including technical or scientific terms, have the same meaning as commonly understood by a person of ordinary skill in the technical field to which the present invention pertains. Terms defined in commonly used dictionaries should be interpreted as having a meaning consistent with the meaning in the context of the related technology, and unless explicitly defined in the present application, should not be interpreted in an ideal or excessively formal sense. No.

Hereinafter, embodiments according to the present invention will be described in detail with reference to the attached drawings.

Figure 1 is a diagram showing the schematic configuration of a vaccine management system 1 according to an embodiment of the present invention.

Referring to Figure 1, the vaccine management system 1 according to an embodiment of the present invention includes an on-site terminal 10, an on-site code recognition device 20, a vaccine management terminal 30, and an incoming code recognition device 40. , may include a user terminal 50 and a management server 60.

The field terminal 10 and the field code recognition device 20 may be devices provided at the vaccine vaccination site. Here, the vaccination site may be a location included in the medical institution or a location outside the medical institution.

The vaccine management terminal 30 and the receipt code recognition device 40 may be devices installed in the medical institution's vaccine storage location where the vaccine is received and registered at the medical institution.

The user terminal 50 is a terminal owned by a person to be vaccinated or vaccinated, and may be composed of a plurality of terminals.

The management server 60 can generate a subject identification code for each vaccination subject, which will be described later, and collect and manage the subject identification code and vaccine identification code for vaccination identified in the vaccine management terminal 30. Furthermore, the management server 60 can generate and analyze big data based on information on accumulated vaccines used by the vaccine management terminal 30, thereby predicting the optimal vaccine demand by period/use, and further. Furthermore, automation of vaccine inventory management based on predicted demand can also be performed.

Meanwhile, the field terminal 10, vaccine management terminal 30, user terminal 50, and management server 60 may be connected to each other through the information and communication network 70. The information and communication network 70 is, for example, a wired network or mobile radio communication network, such as a local area network (LAN), a wide area network (WAN), or a value added network (VAN). network), satellite communication network, Bluetooth, Wibro (Wireless Broadband Internet), HSDPA (High Speed Downlink Packet Access), etc.

Hereinafter, the components of the vaccine management system 1 will be described in more detail as follows.

The field terminal 10 may be a processor-based device installed at a medical site where vaccines are administered, and may include a camera, a communication unit, and a display unit. For example, the field terminal 10 may be various smart devices such as a smartphone, smart note, tablet PC, smart TV, or wearable computer. A vaccination app for administering a vaccine may be installed and executed on the field terminal 10.

The field code recognition device 20 may be a scanner device installed in a medical field, and may be connected to the field terminal 10 through a wired or short-range wireless communication method (for example, Bluetooth). In other words, the vaccination app can be executed in conjunction with the on-site code recognition device 20.

The on-site code recognition device 20 can recognize the subject identification code, which is a unique identification code of a vaccination subject who visited the medical site, and transmit it to the on-site terminal 10. For example, as shown in (a) of FIG. 2, the field code recognition device 20 can recognize the subject identification code 210 displayed on the display unit of the user terminal 50. As described above, the subject identification code 210 may be generated in the management server 60 and transmitted to the user terminal 50.

In addition, the field code recognition device 20 recognizes the vaccine identification code for vaccination printed on the outside of the syringe for administering the vaccine with the vaccine accommodated inside or the vaccine identification code for vaccination printed on the outside of the vial containing the vaccine inside. can do. Hereinafter, embodiments of the present invention will be described assuming only the situation where the vaccine identification code for inoculation is printed on the syringe.

Referring to (b) of FIG. 2, the vaccine identification code 220 for vaccination may be attached to a film and printed on the outer surface of the syringe 80. At this time, the vaccination vaccine identification code 220 may include information on the drug name of the vaccination vaccine. In addition, the lot number 230 of the inoculation vaccine may be further printed on the syringe 80 adjacent to the inoculation vaccine identification code 220. In other words, the vaccination vaccine identification code 220 includes only information on the drug name of the vaccination vaccine, and may not include information such as lot number 230 and expiration date.

Meanwhile, the lot number of a vaccine refers to a number assigned to a vaccine that is manufactured under the same manufacturing conditions and has uniform characteristics and quality, and is also called a “manufacturing number.”

Referring again to FIG. 1, the vaccine management terminal 30 may be a processor-based device installed at a specific location of a medical institution where vaccines are received and registered, and may include a communication unit and a display unit. For example, the vaccine management terminal 30 may be a personal computer (PC) or a smart device. The vaccine management terminal 30 may have a vaccine management app installed and run for storing vaccines.

The arrival code recognition device 40 may be a scanner device that recognizes the vaccine identification code for arrival printed on a vaccine packaging container (for example, a paper box), and the arrival code recognition device 40 is connected to the vaccine management terminal 30 and Communication connection may be made through a wired method or a short-range wireless communication method (for example, Bluetooth). In other words, the vaccine management app can be executed in conjunction with the receipt code recognition device 40.

Specifically, the vaccine may be received as a unit of vaccine packaging container, and two or more vaccines (i.e., vaccine vials) may be accommodated within the vaccine packaging container. For example, 50 vaccines can be accommodated in a vaccine packaging container. At this time, two or more vaccines have the same lot number and the same expiration date. In other words, two or more vaccines may have uniform characteristics and quality. Therefore, the vaccine identification code for receipt printed on the vaccine packaging container may be the vaccine identification code for receipt of each of two or more vaccines.

According to an embodiment, the vaccine identification code for stocking may include at least one of the vaccine drug name, manufacturer, lot number, expiration date, and stocking quantity. As an example, referring to Figure 3, the vaccine packaging box 300 may be printed with a vaccine identification code 310 for receipt, which includes only the drug name and manufacturer information of the vaccine, and the lot number, expiration date, and receipt of the vaccine. The quantity may be printed on the container in the vaccine packaging box 300 adjacent to the vaccine identification code 310 for receipt.

Again, referring to Figure 1, the warehousing code recognition device 40 can recognize the warehousing vaccine identification code printed on the vaccine packaging container and transmit it to the vaccine management terminal 30, and the vaccine management terminal 30 can recognize the warehousing vaccine identification code printed on the vaccine packaging container. A variety of information can be extracted from the vaccine identification code, and the extracted information can be used to register vaccines for delivery.

In particular, the vaccine management app running on the vaccine management terminal 30 displays the vaccine registration interface on the display unit of the vaccine management terminal 30, and enters various information extracted from the vaccine identification code for stocking into the vaccine registration interface. You can register vaccines for receipt. As an example, the drug name and manufacturer information of the incoming vaccine can be extracted from the incoming vaccine identification code and automatically entered into the vaccine registration interface, and the lot number, expiration date, and incoming quantity of the incoming vaccine can be printed on the vaccine packaging container. Administrators of medical institutions can manually fill in the information using the printed information. However, the present invention is not limited to this.

Through the information described above, various incoming vaccines can be registered. At this time, information about the vaccine being registered, that is, vaccine management information, may include information on drug name, manufacturer, lot number, expiration date, and stocked quantity.

In particular, the vaccine management terminal 30 can store vaccine management information for each lot number based on the lot number of the vaccine. As described above, vaccines with the same lot number have uniform characteristics and quality, so in order to easily manage the vaccine and easily track the vaccine in the event of a vaccination accident, the vaccine management terminal 30 separates the vaccines by lot number. Vaccine management information can be saved.

FIG. 4 is a diagram illustrating an example of a vaccine registration interface displayed on the vaccine management terminal 30. Referring to Figure 4, the received and registered vaccines can be managed by lot number by drug name, manufacturer, expiration date, received quantity, and remaining quantity. That is, vaccine management information can be managed by lot number.

Referring again to FIG. 1, the user terminal 50 is a terminal owned by a person to be vaccinated or vaccinated, and may include a communication unit and a display unit. For example, the user terminal 50 may be various smart devices such as smartphones. A user app for vaccination and self-diagnosis may be installed and executed on the user terminal 50. Through the user app, identity information for issuing a subject identification code can be transmitted to the management server 60, self-diagnosis questionnaire information can be displayed from the management server 60, and a self-diagnosis status corresponding to the self-diagnosis questionnaire information. Information can be transmitted to the management server 60, and other post-management can be performed in conjunction with the management server 60.

Hereinafter, the operation method of the vaccine management system 1, that is, the method of providing vaccination services, will be described in more detail.

Figures 5 and 6 are flowcharts of a method for providing vaccination services according to an embodiment of the present invention, and Figures 7 to 10 are diagrams showing the display unit of the field terminal 10 according to an embodiment of the present invention. This diagram shows the displayed screens. At this time, the screens of FIGS. 7 to 10 may be execution screens of the vaccination app of the field terminal 10.

Before explaining the steps shown in FIGS. 5 and 6, the initial screen of the vaccination app of the field terminal 10 is described as follows.

Referring to FIG. 7, the field terminal 10 may have a camera 110 installed on the side where the display unit is provided. The camera 110 can capture images of the vaccination site, and in particular, it can capture images of the vaccination site where vaccination recipients and/or medical staff are located.

Additionally, the execution screen of the vaccination app can display various information to vaccination recipients and medical staff. At this time, the screen of the vaccination app may include a first display area 11 and a second display area 12 aligned left and right.

The first display area 11 may be an area that displays information related to the subject identification code, and the second display area 12 may be an area that displays information related to the vaccine identification code for vaccination. For example, the first display area 11 may be placed on the left side of the execution screen of the vaccination app, and the second display area 12 may be placed on the right side of the execution screen of the vaccination app. However, the present invention is not limited to this, and the first display area 11 may be placed on the right side of the execution screen of the vaccination app, and the second display area 12 may be placed on the left side of the execution screen of the vaccination app. It can be. A detailed description of this will be provided later.

Hereinafter, the process performed for each step will be described in detail with reference to FIG. 5 first.

In step S502, the field code recognition device 20 may recognize the subject identification code of the person receiving the vaccine displayed on the user terminal 50.

In step S504, the field code recognition device 20 may transmit the recognized subject identification code to the field terminal 10.

In step S506, the field terminal 10 may display the identification information of the vaccination subject on the screen of the display unit of the field terminal 10 based on the subject identification code.

Specifically, referring to FIG. 8, when receiving a subject identification code from the field code recognition device 20, the field terminal 10 collects the identity information of the person to be vaccinated (i.e., “vaccinated person information” in FIG. 8). It can be displayed in the first display area 11 of the screen. At this time, the field terminal 10 may be performed in conjunction with the management server 60, the identity information of the vaccination subject may be registered in advance in the management server 50, and the field terminal 10 may be operated by the management server ( The identity information of the person to be vaccinated can be received from 50) and displayed in the first display area 11 of the screen. Here, the identity information of the vaccine recipient may include information on the vaccine recipient's name, gender, date of birth, and phone number.

Referring again to FIG. 5, in step S508, the field code recognition device 20 can recognize the vaccine identification code for vaccination printed on the syringe containing the vaccine for vaccination.

In step S510, the field code recognition device 20 may transmit the recognized vaccine identification code for vaccination to the field terminal 10.

In step S512, the field terminal 10 displays the first vaccination information consisting of N (an integer of 1 or more) sub-vaccination information based on the vaccination vaccine identification code on the display unit of the field terminal 10. It can be displayed on the screen.

Hereinafter, the detailed steps of step S512 will be described with reference to FIG. 6.

In step S5212, the field terminal 10 may extract information on the drug name of the inoculation vaccine from the inoculation vaccine identification code, and in step S5212, the field terminal 10 may extract information on the drug name of the inoculation vaccine. Can be transmitted to the vaccine management terminal 30 through the management server 60.

In this case, as described above, the vaccine management terminal 30 stores vaccine management information for each lot number. Therefore, in step S5213, the vaccine management terminal 30 selects N pieces of vaccine management information with the same vaccine drug name from among the vaccine management information for each lot number based on the drug name of the vaccine for vaccination received from the field terminal 10. And in step S5214, the vaccine management terminal 30 can transmit N pieces of vaccine management information to the field terminal 10.

Then, in step S5215, the field terminal 10 may generate first vaccination information consisting of N sub-vaccination information based on the N vaccine management information, and in step S5216. , the field terminal 10 can display the first vaccination information on the second display area 12 of the screen.

Here, each of the N pieces of sub-vaccination information may have a corresponding relationship with the N pieces of vaccine management information. In particular, the sub-vaccination information may be configured to include only part of the vaccine management information. As an example, the sub-vaccination information may include lot number, remaining quantity, expiration date, and registration period information among the information included in the vaccine management information.

FIG. 9 shows an example in which first vaccination information is displayed in the second display area 12 of the screen. Referring to FIG. 9, two sub-vaccination information 121 and 122 with the same vaccine drug name may be aligned vertically and displayed on the second display area 12 of the screen. At this time, as described above, each of the two sub-vaccination information 121 and 122 may include information on the lot number, remaining quantity, expiration date, and registration period. In particular, the lot number information that distinguishes the vaccine from other vaccines may be displayed in a larger size and emphasized than the remaining quantity, expiration date, and registration period information. Therefore, vaccine recipients and medical staff can easily distinguish lot numbers.

Referring again to FIG. 5, in step S514, the field terminal 10 may receive a first event signal for selecting the first sub-vaccination information among the N pieces of sub-vaccination information.

Here, the first event signal may be a touch event signal in which a medical staff touches the display unit of the field terminal 10. And, as described in FIG. 2, the lot number 230 of the inoculation vaccine may be printed adjacent to the inoculation vaccine identification code 220 on the syringe 80, and the medical staff may use the inoculation printed on the syringe 80. The first event signal can be input by comparing the lot number 230 of the vaccine and N sub-vaccination information. Hereinafter, it is assumed that the first sub-vaccination information 121 having the same lot number as the lot number 230 of the vaccination vaccine is selected among the two sub-vaccination information 121 and 122 shown in FIG. 9. do.

In step S516, the field terminal 10 may generate second vaccination information based on the first sub-vaccination information and display it on the screen of the display unit of the field terminal 10.

Specifically, when the first sub-vaccination information is selected, the field terminal 10 may select the first vaccine management information corresponding to the first sub-vaccination information among the N pieces of vaccine management information, and select the first vaccine management information corresponding to the first sub-vaccination information. Among the management information, second vaccination information including the drug name, manufacturer, lot number, and expiration date of the vaccine can be generated and displayed in the second display area 12 of the screen. In other words, the second vaccination information may be information that reconfirms the first sub-vaccination information selected by the medical staff.

FIG. 10 shows an example in which second vaccination information 123 is displayed in the second display area 12 of the screen.

Referring again to FIG. 5, in step S518, the field terminal 10 may receive a second event signal confirming information for the second vaccination.

Here, the second event signal may also be a touch event signal in which the medical staff touches the display unit of the field terminal 10. For example, referring to Figure 10, the medical staff confirms the identity information of the vaccination subject and the information for the second vaccination with the vaccination subject and then clicks the confirmation button (13) so that the second event signal is transmitted to the field terminal (10). can be entered.

In step S520, the field terminal 10 may transmit the identity information of the vaccination target and the second vaccination information to the management server 60.

In step S522, the management server 60 may generate vaccination guidance information based on the identity information of the vaccination subject and the second vaccination information. Here, the vaccination guidance information may include the identity information of the vaccination subject, vaccination date and time, vaccination location, drug name of the vaccination vaccine, manufacturer, and lot number. Here, the vaccination date and time may correspond to the input time of the second event signal, and the vaccination site may correspond to the location of the field terminal 10.

In step S524, the management server 60 may transmit vaccination guidance information to the user terminal 50 of the person to be vaccinated, and in step S526, the user terminal 50 may transmit vaccination guidance information to the display unit. It can be displayed in .

Additionally, in step S528, the management server 60 may generate and store vaccination history information of the vaccination target (i.e., vaccine recipient) based on the vaccination guide information. At this time, steps S502 to S528 may be performed for all of the plurality of vaccine recipients, and the management server 60 may record the vaccination history of the plurality of vaccine recipients by lot number, similar to the above-mentioned. Information can be saved.

According to the embodiment, when steps S502 to S528 are all performed, the medical staff can inoculate the vaccine recipient with an inoculation vaccine having a confirmed lot number.

Meanwhile, although not shown in FIG. 5, after step S518, the field terminal 10 sends a command to reduce the remaining quantity of the first vaccine management information corresponding to the vaccine for vaccination to the vaccine management server 60. It can be transmitted to the management terminal 30. In this case, the vaccine management terminal 30 may reduce the remaining quantity of the first vaccine management information by “1” based on the received remaining quantity reduction command. That is, when the vaccine for vaccination is administered to a person to be vaccinated, the remaining quantity of the first vaccine management information stored in the vaccine management terminal 30 may be reduced by “1”. Accordingly, the remaining quantity of first vaccine management information corresponding to the vaccine for inoculation can be automatically managed without the involvement of medical staff.

In short, the method of providing a vaccination service according to an embodiment of the present invention is a method that must be confirmed for vaccination of a vaccination subject based on the subject identification code and vaccination vaccine identification code recognized by the field code recognition device 20. Check information can be displayed on the screen of the field terminal 10. At this time, the screen of the field terminal 10 may include first and second display areas 11 and 12 that are displayed simultaneously, and the first display area 11 contains the vaccination corresponding to the subject identification code among the check information. The subject's identity information may be displayed, and vaccination information corresponding to the vaccination vaccine identification code among the check information may be displayed in the second display area 12.

At this time, the vaccination information may include first and second vaccination information. The first vaccination information may include N sub-vaccination information with the same drug name but different lot numbers. The second vaccination information may be vaccine management information related to the first sub-vaccination information having the same lot number as the lot number of the vaccine printed on the syringe among the N pieces of sub-vaccination information.

The identity information of the vaccination subject and the information on the vaccine for vaccination (i.e., vaccination information) are simultaneously displayed on the screen of the field terminal 10, so that the vaccination subject and medical staff can receive the vaccine to be administered to the vaccination subject at the access site. It is easy to check whether the vaccine recipient is the same as the vaccine applied for. Accordingly, misvaccination accidents in which a vaccine recipient is administered a different vaccine than the intended vaccine can be prevented in advance.

In addition, in the past, there were many situations where medical staff at the vaccination site performed vaccination by only checking the drug name of the vaccine without checking the lot number. In particular, when registering the completion of vaccination, a situation occurred where medical staff did not accurately register the lot number of the vaccine accessed by the vaccinated person, but registered a random lot number. In this case, even if the drug name is the same, if the lot number is different, it cannot be considered the same vaccine. Therefore, if an adverse reaction occurs after one vaccine recipient has received the vaccine, it is not possible to find another vaccine recipient who has received the same vaccine, so the vaccine must be administered. A problem arose that caused the accident to escalate. However, according to the present invention, the lot number must be confirmed at the time of vaccination, the vaccine is administered to the person receiving the vaccine, and the completion of vaccination is automatically registered, so vaccine misregistration accidents can also be prevented in advance.

Meanwhile, the follow-up management of the vaccinated person performed after step (S528) is explained as follows. At this time, as described above, it is assumed that the management server 60 stores vaccination history information of a plurality of vaccine recipients for each lot number. In addition, the contents described below are performed in conjunction with a plurality of user terminals 50 and the management server 60, but may be performed at separate points in time for each user terminal 50.

First, the management server 60 may transmit self-diagnosis questionnaire information to a plurality of user terminals 50 owned by each of the plurality of vaccine recipients. Self-diagnosis questionnaire information can be confirmed to the vaccine recipient through the user app installed on the user terminal 50.

For example, the self-diagnosis questionnaire information includes first self-diagnosis questionnaire information for cardiopulmonary symptoms (including details of “cough,” “phlegm,” “breath,” “chest pain,” and “palpitations”), and first self-diagnosis questionnaire information for cardiopulmonary symptoms (including details of “cough,” “phlegm,” “breath,” “chest pain,” and “palpitations”), 2nd self-diagnosis questionnaire information (including details of “headache,” “dizziness,” “sleep disturbance,” “poor memory,” and “numbness/numbness”), 3rd self-diagnosis questionnaire information about systemic symptoms (“ (includes details of "low energy", "weight loss", "fatigue"), 4th self-diagnosis questionnaire information on digestive symptoms ("heartburn", "abdominal pain/stomach pain", "diarrhea", "nausea/vomiting", Information on the fifth self-assessment questionnaire for psychiatric symptoms (including details of “indigestion” and “gas trouble”), information on the fifth self-assessment questionnaire for psychiatric symptoms (including details of “depression,” “anxiety,” and “difficulty concentrating”), and information on the fifth self-assessment questionnaire for ENT symptoms. 6 Self-diagnosis questionnaire information (including details of “poor sense of smell”, “poor sense of taste”), 7th self-diagnosis questionnaire information for eye symptoms (including details of “keratoconjunctivitis”, “poor vision”), skin Information on the 8th self-diagnosis questionnaire for symptoms (including details of “hair loss” and “skin rash”), information on the 9th self-diagnosis questionnaire for gynecological symptoms (including details of “menstrual irregularity” and “abnormal vaginal bleeding”) (including) and the 10th self-diagnosis questionnaire information on urinary symptoms (including details of “decreased sexual function” and “abnormal urinary pattern”). This is as shown in (a) of Figure 11.

Next, each of the plurality of user terminals 50 may generate self-diagnosis status information of the vaccine recipient corresponding to the self-diagnosis questionnaire information based on the click event of the vaccine recipient and transmit it to the management server 60.

As an example, referring to (b) of FIG. 11, the user can select at least one detailed information corresponding to the area in which the user has pain among the detailed information for each self-diagnosis questionnaire displayed on the user terminal 50. Then, referring to (c) of FIG. 11, the user terminal 50 may display a pain level input object for each selected detailed information, and the user may indicate his or her pain level through the pain level input object for each selected detailed information ( That is, any one level from 1 to 5) can be entered. Accordingly, self-diagnosis status information of the vaccinated person may be generated.

Continuing, the management server 60 may store self-diagnosis status information for each of a plurality of vaccine recipients for each vaccine lot number.

Thereafter, the management server 60 may track abnormal reactions of multiple vaccine recipients based on self-diagnosis status information stored for each vaccine lot number.

That is, as described above, since vaccines with the same lot number are presumed to be uniform vaccines, the management server 60 can track adverse reactions of multiple vaccine recipients by lot number.

The details of tracking adverse reactions in multiple vaccine recipients by lot number are as follows. At this time, tracking of adverse reactions based on the vaccine recipient who received the vaccine corresponding to the first lot number among the plurality of lot numbers will be described.

First, the management server 60 may calculate the number of vaccine recipients with adverse reactions among a plurality of vaccine recipients who have been vaccinated with the first vaccine corresponding to the first lot number.

Here, an adverse reaction vaccine recipient may be defined as a vaccine recipient for the first vaccine whose level of abnormal symptom exceeds a threshold level. At this time, the management server 50 may set the level of abnormal symptoms in various ways based on the level of detailed information for each self-diagnosis questionnaire information. If no adverse reaction vaccine recipient is present, the instructions below do not apply.

Next, the management server 60 may transmit an adverse reaction notification message for the adverse reaction vaccine recipient to the terminal of the medical institution. Here, the medical institution may be a medical institution visited by the adverse reaction vaccine recipient to receive the first vaccine. For example, when adverse reactions such as headache and vomiting are detected in vaccine recipient A, the management server 60 sends an adverse reaction notification message such as “Adverse reactions such as headache and vomiting were detected in vaccine recipient A. Please check.” It can be transmitted to the terminal of a medical institution along with information on the self-diagnosis status of vaccine recipient A. Accordingly, it is possible to prevent a situation where adverse reactions in a vaccine recipient become more severe.

In addition, the management server 60 may determine whether the number of vaccine recipients with adverse reactions exceeds a preset threshold number. In other words, the management server 60 can calculate the adverse reaction rate defined as the ratio of the number of adverse reaction vaccine recipients to the total number of plural vaccine recipients who received the first vaccine, and the adverse reaction rate is preset. It can be determined whether a threshold ratio (for example, 2%) is exceeded.

At this time, if the management server 60 determines that the adverse reaction rate exceeds the threshold rate, the management server 60 may use the user terminal of the vaccine recipient who received the first vaccine but did not develop an adverse reaction. An intensive management notification message can be transmitted, and the user terminal of a vaccine recipient who has not experienced an adverse reaction can display an intensive management notification message. For example, the intensive care notification message may be a message such as “An adverse reaction has been detected for the first vaccine, so please closely check the health status of xxx.” Accordingly, according to the present invention, the problem of expanding vaccination accidents can be further prevented.

Meanwhile, according to another embodiment of the present invention, the management server 60 can calculate statistics by collecting self-diagnosis status information of a plurality of vaccine recipients. In other words, the vaccine management system (1) according to the present invention can provide statistical analysis data on vaccine side effects to medical staff (vaccination management organizations), and thereby implement a centralized vaccine control system such as side effect aggregate status and side effect vaccine tracking. You can. At this time, the real-time side effect aggregate data can be provided to the vaccination management agency in statistical numbers by gender, age, product, side effect reaction time after vaccination, type of side effect, etc. through the self-diagnosis described above, and backtracking of vaccine side effects and side effects. It will be possible to compile data on the occurrence of side effects in vaccinated people, including recalls.

In particular, the management server 60 may calculate an average pain level by gender and age for each of a plurality of detailed items of self-diagnosis status information. At this time, with respect to the first sub-item among the plurality of sub-items, if the pain level of the first vaccine recipient among the plurality of vaccine recipients exceeds the average pain level by gender and/or age, the user terminal of the first vaccine recipient or A notification message that exceeds the pain level can be sent to the medical institution's terminal. Through this, the first vaccine recipient can be managed centrally.

Meanwhile, the field terminal 10 can be mounted on a desk provided at the vaccination site, and the medical staff can perform the act of vaccinating a person to be vaccinated on the front side of the field terminal 10. And, as described in FIGS. 7 to 10, the identity information of the vaccination subject may be displayed in the first display area 11 disposed on the left side of the screen of the vaccination app, and on the right side of the screen of the vaccination app. Vaccination information may be displayed in the disposed second display area 12. Generally, those eligible for vaccination first verify their identity information and then confirm their vaccination information later.

At this time, depending on the structure or movement line of the vaccination site, the person to be vaccinated may be located on the left side of the field terminal 10 or on the right side of the field terminal 10. In particular, when a person to be vaccinated is located on the right side of the field terminal 10, the person to be vaccinated generally first checks the second display area 12 on the right side of the screen of the vaccination app in the same direction as his or her location. , Since vaccination information is displayed in the second display area (12), the person receiving the vaccine checks his or her identification information displayed in the first display area (11) and then receives the vaccination information displayed in the second display area (12). Check again. In other words, the direction of the vaccination subject's gaze with respect to the field terminal 10 is “second display area 12 → first display area 11 → second display area 12.” This may cause discomfort to those receiving the vaccine.

Therefore, according to an embodiment of the present invention, the field terminal 10 is based on at least one of the location of the vaccination subject at the vaccination site and the location of the medical staff administering the vaccine at the vaccination site. The arrangement positions of the first and second display areas 11 and 12 on the screen can be set.

Specifically, the screen of the field terminal 10 may be divided into a left area and a right area. Meanwhile, in FIGS. 7 to 10, the first display area 11 is displayed on the left side of the screen of the field terminal 10, and the second display area 12 is displayed on the right side of the screen of the field terminal 10. It was explained as being possible.

In addition, the field terminal 10 can generate an image of the vaccination site by photographing the vaccination site through the camera 110, and calculate the location of the medical staff who will administer the vaccine by analyzing the generated image of the vaccination site. can do. To this end, vaccination apps may include video analysis tools.

At this time, when the medical staff's location is on the left side of the field terminal 10, the first display area 11 may be placed on the right side of the screen of the field terminal 10, as shown in FIG. 12, and the second display area 11 may be placed on the right side of the screen of the field terminal 10. The display area may be placed in the left area of the screen of the field terminal 10. And, when the medical staff's location is on the right side of the field terminal 10, as described in FIGS. 6 to 10, the first display area 11 may be placed in the left area of the screen of the field terminal 10, The second display area 12 may be placed in the right area of the screen of the field terminal 10.

In particular, medical staff hold an on-site code identification device (20) in their hands to administer the vaccine. This can be a standard for distinguishing between medical staff and vaccine recipients. That is, the field terminal 10 can extract the shape of the field code identification device 20 from the image of the vaccination site, and correspond the position of the shape of the field code identification device 20 to the location of the medical staff. Meanwhile, shape extraction of the field code identification device 20 may be performed based on a template matching algorithm.

Specifically, if the extracted shape of the field code recognition device 20 is located in the left area in the image of the vaccination site, the field terminal 10 may determine that the location of the medical staff is to the left of the field terminal 10. . In addition, when the shape of the field code recognition device 20 is located in the right area in the image of the vaccination site, the field terminal 10 may determine that the location of the medical staff is on the right side of the field terminal 10.

Additionally, embodiments of the present invention may be implemented in the form of program instructions that can be executed through various computer means and recorded on a computer-readable medium. The computer-readable medium may include program instructions, data files, data structures, etc., singly or in combination. Program instructions recorded on the medium may be specially designed and constructed for the present invention or may be known and usable by those skilled in the art of computer software. Examples of computer-readable recording media include magnetic media such as hard disks, floppy disks, and magnetic tapes, optical media such as CD-ROMs and DVDs, and magnetic media such as floptical disks. -Includes optical media (magneto-optical) and hardware devices specifically configured to store and execute program instructions, such as ROM, RAM, flash memory, etc. Examples of program instructions include machine language code, such as that produced by a compiler, as well as high-level language code that can be executed by a computer using an interpreter, etc. The hardware devices described above may be configured to operate as one or more software modules to perform the operations of embodiments of the present invention, and vice versa.

As described above, the present invention has been described with reference to specific details such as specific components and limited embodiments and drawings, but this is only provided to aid the overall understanding of the present invention, and the present invention is not limited to the above embodiments. Various modifications and variations can be made from this description by those skilled in the art to which the present invention pertains. Accordingly, the spirit of the present invention should not be limited to the described embodiments, and the claims described below as well as all modifications that are equivalent or equivalent to the claims shall fall within the scope of the spirit of the present invention.

Claims (16)

A vaccine management terminal that stores vaccine management information for each lot number based on the lot number of the vaccine being received and registered in a medical institution - Each of the vaccine management information for each lot number contains the lot number and drug name of the vaccine being received. Contains -;
An on-site code recognition device that recognizes the subject identification code of the person to be vaccinated and the vaccine identification code for vaccination printed on the syringe or vial; and
Based on the subject identification code and the vaccination vaccine identification code transmitted from the field code recognition device, check information that must be confirmed for vaccination of the vaccination subject is divided into first and second display areas and displayed on the screen. Including field terminal;
The first display area displays identification information of the vaccination subject corresponding to the subject identification code among the check information, and the second display area displays vaccination information corresponding to the vaccination vaccine identification code among the check information. Display ,
The field terminal extracts the drug name of the vaccine for vaccination based on the identification code of the vaccine for vaccination transmitted from the field code recognition device and transmits it to the vaccine management terminal,
The vaccine management terminal selects N (an integer of 1 or more) vaccine management information among the vaccine management information for each lot number based on the drug name of the vaccine for inoculation and transmits it to the field terminal,
The field terminal displays the vaccination information in the second display area based on the N pieces of vaccine management information,
Vaccine management system.
According to paragraph 1,
Each of the vaccine management information for each lot number further includes at least one of the manufacturer, expiration date, receipt quantity, and remaining quantity of the vaccine being received.
Vaccine management system.
According to paragraph 2,
It further includes a receipt code recognition device that recognizes the receipt vaccine identification code printed on the vaccine packaging container,
The vaccine management terminal extracts the lot number and drug name of the incoming vaccine from the incoming vaccine identification code transmitted from the incoming vaccine identification code, and identifies at least one of the manufacturer, the expiration date, and the incoming quantity. Extract one more and store vaccine management information for each lot number,
Vaccine management system.
delete According to paragraph 2,
The field terminal displays first vaccination information consisting of N sub-vaccination information among the vaccination information in the second display area,
Each of the N pieces of sub-vaccination information includes the lot number, the expiration date, and the remaining quantity of the corresponding vaccine management information among the N pieces of vaccine management information,
In the second display area, the lot number of the sub-vaccination information is displayed with emphasis over the expiration date and the remaining quantity of the sub-vaccination information.
Vaccine management system.
According to clause 5,
When a first event signal for selecting the first sub-vaccination information among the N pieces of sub-vaccination information is input, the field terminal selects the first sub-vaccination information among the vaccination information based on the first sub-vaccination information. Generate information for second vaccination and display it in the second display area,
The second vaccination information includes the drug name, the manufacturer, the lot number, and the expiration date of the first vaccine management information corresponding to the first sub-vaccination information among the N vaccine management information,
Vaccine management system.
According to clause 6,
The lot number of the vaccine for inoculation is printed on the syringe or the vial,
The first event signal is input based on the medical staff's confirmation of the lot number of the vaccine for inoculation,
Vaccine management system.
According to clause 6,
When a second event signal confirming the second vaccination information is input, the field terminal transmits a command to reduce the remaining quantity of the first vaccine management information to the vaccine management terminal,
The vaccine management terminal reduces the remaining quantity of the first vaccine management information by “1” based on the command to reduce the remaining quantity.
Vaccine management system.
According to clause 6,
A user terminal held by the person to be vaccinated; and
It further includes a management server connected to communication with the field terminal and the user terminal,
When a second event signal confirming the second vaccination information is input, the field terminal transmits the identification information of the vaccination subject and the second vaccination information to the management server,
The management server generates vaccination guidance information based on the identity information of the vaccination subject and the second vaccination information, and transmits the vaccination guidance information to the user terminal,
The user terminal displays the vaccination guidance information,
The management server generates and stores vaccination history information of the vaccination target based on the vaccination guidance information,
Vaccine management system.
According to paragraph 1,
It further includes a management server that stores vaccination history information of a plurality of vaccine recipients for each lot number of the vaccine,
The management server transmits self-diagnosis questionnaire information to a plurality of user terminals held by each of the plurality of vaccine recipients, receives self-diagnosis status information corresponding to the self-diagnosis questionnaire information from each of the plurality of user terminals, and The self-diagnosis status information of multiple vaccine recipients is stored for each lot number,
The management server tracks abnormal reactions of the plurality of vaccine recipients based on self-diagnosis status information stored for each lot number.
Vaccine management system.
According to clause 10,
For each vaccine recipient who received the vaccine corresponding to the first lot number, the management server:
Calculating an adverse reaction vaccine recipient with self-diagnosis status information corresponding to a preset threshold level, and transmitting an adverse reaction notification message for the adverse reaction vaccine recipient to a terminal of a medical institution visited by the adverse reaction vaccine recipient,
If the number of vaccine recipients with the adverse reaction exceeds the preset threshold number, the vaccine corresponding to the first lot number was administered, but no adverse reaction occurred, and the adverse reaction did not occur in the user terminal of the vaccine recipient. Sending intensive care notification messages to vaccine recipients,
Vaccine management system.
According to clause 10,
The management server calculates an average pain level by gender and age for each of a plurality of detailed items of self-diagnosis status information received from the plurality of vaccine recipients,
With respect to the first sub-item among the plurality of detailed items, when the pain level of the first vaccine recipient among the plurality of vaccine recipients exceeds the average pain level for any one of gender and age, the user terminal of the first vaccine recipient Or, transmitting a notification message that the pain level is exceeded to the terminal of a medical institution,
Vaccine management system.
According to paragraph 1,
The field terminal displays the first and second display areas on the screen of the field terminal based on at least one of the location of the vaccination subject at the vaccination site and the location of the medical staff administering the vaccine at the vaccination site. To set the placement location of
Vaccine management system.
According to clause 13,
The screen of the field terminal is divided into a left area and a right area,
The field terminal is equipped with a camera and calculates the location of the medical staff by analyzing the video of the vaccination site captured by the camera,
When the location of the medical staff is on the left side of the field terminal, the first display area is placed on the right side of the screen of the field terminal, and the second display area is placed on the left side of the screen of the field terminal,
When the location of the medical staff is on the right side of the field terminal, the first display area is placed in the left area of the screen of the field terminal, and the second display area is placed in the right area of the screen of the field terminal,
Vaccine management system.
According to clause 14,
The field terminal extracts the shape of the field code recognition device from the image of the vaccination site,
If the shape of the field code recognition device is located in the left area in the image of the vaccination site, it is determined that the location of the medical staff is to the left of the field terminal,
When the shape of the field code recognition device is located in the right area in the image of the vaccination site, determining that the location of the medical staff is to the right of the field terminal,
Vaccine management system.
In a method of providing vaccination services performed in a vaccine management system including a vaccine management terminal, a field code recognition device, and a field terminal,
The vaccine management terminal stores vaccine management information for each lot number based on the lot number of the vaccine to be received and registered in the medical institution - each of the vaccine management information for each lot number is the lot number and drug name of the vaccine to be received. Contains -;
Recognizing, by the field code recognition device, the subject identification code of the person to be vaccinated and the vaccine identification code for vaccination printed on the syringe or vial, and transmitting the recognition to the field terminal; and
The field terminal, in conjunction with the vaccine management terminal, divides check information that must be confirmed for vaccination of the vaccination subject into first and second display areas based on the subject identification code and the vaccination vaccine identification code. Including, displaying on the screen of the field terminal,
The first display area displays identification information of the vaccination subject corresponding to the subject identification code among the check information, and the second display area displays vaccination information corresponding to the vaccination vaccine identification code among the check information. Display ,
The steps indicated above are:
Extracting, by the field terminal, the drug name of the vaccine for vaccination based on the identification code of the vaccine for vaccination transmitted from the field code recognition device and transmitting it to the vaccine management terminal;
The vaccine management terminal selecting N (an integer of 1 or more) pieces of vaccine management information among the vaccine management information for each lot number based on the drug name of the vaccine for inoculation and transmitting it to the field terminal; and
Including, by the field terminal, displaying the vaccination information on the second display area based on the N pieces of vaccine management information.
How to provide vaccination services.